Your browser doesn't support javascript.
loading
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review.
Cruz, Márcia Waddington.
Afiliação
  • Cruz MW; National Amyloidosis Referral Center-CEPARM, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. mwaddingtoncruz@gmail.com.
Clin Auton Res ; 29(Suppl 1): 19-24, 2019 09.
Article em En | MEDLINE | ID: mdl-31407119
PURPOSE: Autonomic dysfunction is a very common, early and distressing aspect of hereditary transthyretin (ATTR) amyloidosis leading to significant loss of quality of life and morbidity for patients. Although the clinical variability of ATTR has been well characterized as neuropathic, cardiac or mixed phenotype, the extent of autonomic involvement remains poorly understood. Despite the fact that the autonomic nervous system has not been specifically evaluated in any of the clinical trials of tafamidis, and that, for some primary and secondary endpoints used in these trials, the behavior cannot be separated from non-autonomic items, an attempt was made to use published material to indirectly access the efficacy of tafamidis in treating dysautonomia. METHODS: Literature review summarizing the results of primary and secondary endpoints related to the autonomic features used in the original tafamidis trials, the post hoc publications, and real-world data, on the effect of tafamidis on autonomic dysfunction in patients with ATTR amyloidosis. RESULTS: There is some evidence that indirectly demonstrates that tafamidis is safe and could slow or arrest the progression of autonomic neuropathy in patients with ATTR amyloidosis, in addition to its well-described effects to ameliorate sensory-motor peripheral neuropathy. CONCLUSION: Although the current evidence is scarce, tafamidis might be effective in arresting the progression of autonomic neuropathy in patients with ATTR amyloidosis. Tafamidis might be more effective at the early stage of the disease; however, individual responses must be monitored.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Autônomo / Benzoxazóis / Neuropatias Amiloides Familiares Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Clin Auton Res Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Autônomo / Benzoxazóis / Neuropatias Amiloides Familiares Tipo de estudo: Etiology_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Clin Auton Res Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha